AN OBSERVATIONAL RETROSPECTIVE COHORT STUDY OF SYSTEMIC THERAPIES FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (R/R DLBCL), TO COMPARE OUTCOMES TO THOSE FROM TAFASITAMAB + LENALIDOMIDE IN THE L-MIND STUDY.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
MORPHOSYS AG
Cita
AN OBSERVATIONAL RETROSPECTIVE COHORT STUDY OF SYSTEMIC THERAPIES FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (R/R DLBCL), TO COMPARE OUTCOMES TO THOSE FROM TAFASITAMAB + LENALIDOMIDE IN THE L-MIND STUDY. (MOR-TAF-2020-01). MORPHOSYS AG. 2020-2020. IP:ISIDRO JARQUE RAMOS.
Portal de investigación